Christoph Gesenberg
Bristol-Myers Squibb (Germany)(DE)Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Drug Solubulity and Delivery Systems, Fullerene Chemistry and Applications, Advanced Chemical Physics Studies, Computational Drug Discovery Methods, HIV/AIDS drug development and treatment
Most-Cited Works
- → Analysis of Isomers of the Higher Fullerenes by 3He NMR Spectroscopy(1995)117 cited
- → Oral Formulations for Preclinical Studies(2017)68 cited
- → Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection(2014)66 cited
- → Assessing the Risk of pH-Dependent Absorption for New Molecular Entities: A Novel in Vitro Dissolution Test, Physicochemical Analysis, and Risk Assessment Strategy(2013)65 cited
- → Discovery pharmaceutics—Challenges and opportunities(2006)42 cited
- → 3He NMR spectra of highly reduced C60(1997)36 cited
- → Utilization of in vitro Caco‐2 permeability and liver microsomal half‐life screens in discovering BMS‐488043, a novel HIV‐1 attachment inhibitor with improved pharmacokinetic properties(2009)22 cited
- → Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy(2019)21 cited
- → Reaction of cyclopropa[b]naphthalene with 3He@C60(1994)20 cited
- → A high-throughput spectrophotometric approach for evaluation of precipitation resistance(2011)13 cited